- Home
- RXT vs TKNO Comparison
RXT vs TKNO Comparison
Compare RXT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- TKNO
- Stock Information
- Founded
- RXT 1998
- TKNO 1996
- Country
- RXT United States
- TKNO United States
- Employees
- RXT N/A
- TKNO N/A
- Industry
- RXT EDP Services
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- RXT Technology
- TKNO Health Care
- Exchange
- RXT Nasdaq
- TKNO Nasdaq
- Market Cap
- RXT 280.1M
- TKNO 256.9M
- IPO Year
- RXT 2020
- TKNO 2021
- Fundamental
- Price
- RXT $1.44
- TKNO $4.40
- Analyst Decision
- RXT Hold
- TKNO
- Analyst Count
- RXT 5
- TKNO 0
- Target Price
- RXT $1.58
- TKNO N/A
- AVG Volume (30 Days)
- RXT 1.1M
- TKNO 153.5K
- Earning Date
- RXT 11-11-2025
- TKNO 11-06-2025
- Dividend Yield
- RXT N/A
- TKNO N/A
- EPS Growth
- RXT N/A
- TKNO N/A
- EPS
- RXT N/A
- TKNO N/A
- Revenue
- RXT $2,693,100,000.00
- TKNO $38,923,000.00
- Revenue This Year
- RXT N/A
- TKNO $9.52
- Revenue Next Year
- RXT $1.59
- TKNO $15.20
- P/E Ratio
- RXT N/A
- TKNO N/A
- Revenue Growth
- RXT N/A
- TKNO 11.40
- 52 Week Low
- RXT $1.00
- TKNO $3.94
- 52 Week High
- RXT $3.41
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- RXT 56.67
- TKNO 48.55
- Support Level
- RXT $1.32
- TKNO $3.94
- Resistance Level
- RXT $1.52
- TKNO $4.72
- Average True Range (ATR)
- RXT 0.10
- TKNO 0.29
- MACD
- RXT 0.01
- TKNO 0.03
- Stochastic Oscillator
- RXT 73.33
- TKNO 59.35
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.